Development code · Small Molecule
REL-1017
REL-1017 is a development code for Esmethadone (REL-1017), developed by Relmada Therapeutics, Inc..
- Status
- Discontinued for Major depressive disorder
- Mechanism
- GluN2D Antagonist
- Developer
- Relmada Therapeutics, Inc.
Programs
- Esmethadone (REL-1017) for Major depressive disorderDiscontinuedDiscontinued
Also known as
- dextromethadone
- d-methadone
- esmethadone
- (S)-(+)-methadone
- 5653-80-5